Vertex Pharmaceuticals (VRTX) Amortizatization of Intangibles (2010 - 2011)

Vertex Pharmaceuticals' (VRTX) quarterly Amortizatization of Intangibles came in at $6.6 million in Q4 2011, up 83.66% year-on-year from $3.6 million in Q4 2010, and up 145.52% quarter-over-quarter from $2.7 million in Q3 2011.

Vertex Pharmaceuticals (VRTX) Amortizatization of Intangibles (2010 - 2011) Analysis & Trends

Vertex Pharmaceuticals' Amortizatization of Intangibles history runs 2 years deep, the most recent figure standing at $6.6 million for Q4 2011.

  • On a quarterly basis, Amortizatization of Intangibles rose 83.66% year-over-year to $6.6 million in Q4 2011; TTM through Dec 2011 was $19.4 million, a 42.73% increase from a year earlier, with the FY2011 full-year figure at $18.4 million, up 35.47% from the prior year.
  • Amortizatization of Intangibles advanced to $6.6 million in Q4 2011 per VRTX's latest filing, from $2.7 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $6.6 million in Q1 2011 and bottomed at $2.7 million in Q3 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Alnylam Pharmaceuticals 37.29 Bn 34.28 Bn 959.66 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2011 6.55 Mn
Dec 31, 2011 6.55 Mn
Sep 30, 2011 2.67 Mn
Sep 30, 2011 2.67 Mn
Mar 31, 2011 6.61 Mn
Mar 31, 2011 6.61 Mn
Dec 31, 2010 3.57 Mn
Dec 31, 2010 3.57 Mn
Sep 30, 2010 3.45 Mn
Sep 30, 2010 3.45 Mn
Jun 30, 2010 3.34 Mn
Jun 30, 2010 3.34 Mn
Mar 31, 2010 3.23 Mn
Mar 31, 2010 3.23 Mn